BK channel openers inhibit ROS production of isolated rat brain mitochondria

To delineate the potential mechanism of neuroprotective effects of potassium channel openers we have investigated, how Ca 2+-activated large conductance potassium channel (BK Ca channel) openers influence the production of reactive oxygen species (ROS) by rat brain mitochondria, since mitochondrial...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Experimental neurology 2008-08, Vol.212 (2), p.543-547
Hauptverfasser: Kulawiak, Bogusz, Kudin, Alexei P., Szewczyk, Adam, Kunz, Wolfram S.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:To delineate the potential mechanism of neuroprotective effects of potassium channel openers we have investigated, how Ca 2+-activated large conductance potassium channel (BK Ca channel) openers influence the production of reactive oxygen species (ROS) by rat brain mitochondria, since mitochondrial generation of ROS is known to have a crucial influence on neuronal survival. We studied the effects of BK Ca channel openers CGS 7184 and NS 1619 on hydrogen peroxide production rate of isolated rat brain mitochondria. In K +-containing media 3 μM of both channel openers reduced the hydrogen peroxide production rates by approximately 20%. This effect was not observed in Na +-containing media. This potassium-dependent partial inhibition of hydrogen peroxide production was found to be sensitive to the selective blockers of BK Ca channel iberiotoxin and charybdotoxin applied in nanomolar concentrations. Taken together, our data are compatible with the viewpoint that the opening of a Ca 2+-activated large conductance potassium channel being localised in the inner membrane of brain mitochondria inhibits ROS production by respiratory chain complex I. This finding is suggested to explain the beneficial effects of BK potassium channel openers on neuronal survival.
ISSN:0014-4886
1090-2430
DOI:10.1016/j.expneurol.2008.05.004